Technical Analysis for PTIX - Protagenic Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.60 | 0.29% | 0.00 |
PTIX closed up 2.44 percent on Wednesday, November 20, 2024, on 12 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.29% | |
50 DMA Resistance | Bearish | 0.29% | |
MACD Bearish Centerline Cross | Bearish | 0.29% | |
Calm After Storm | Range Contraction | 0.29% | |
Wide Bands | Range Expansion | 0.29% | |
Oversold Stochastic | Weakness | 0.29% | |
Calm After Storm | Range Contraction | 2.74% | |
NR7 | Range Contraction | 2.74% | |
Narrow Range Bar | Range Contraction | 2.74% | |
Inside Day | Range Contraction | 2.74% |
Alert | Time |
---|---|
Gap Up Closed | 33 minutes ago |
Gap Up Partially Closed | 33 minutes ago |
Down 1% | 33 minutes ago |
Gapped Up (Partial) | about 3 hours ago |
50 DMA Resistance | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Mood Disorders Pre Clinical Biopharmaceutical
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.87 |
52 Week Low | 0.49 |
Average Volume | 354,286 |
200-Day Moving Average | 0.96 |
50-Day Moving Average | 0.63 |
20-Day Moving Average | 0.64 |
10-Day Moving Average | 0.65 |
Average True Range | 0.12 |
RSI (14) | 46.81 |
ADX | 40.29 |
+DI | 30.37 |
-DI | 12.11 |
Chandelier Exit (Long, 3 ATRs) | 0.73 |
Chandelier Exit (Short, 3 ATRs) | 0.88 |
Upper Bollinger Bands | 0.75 |
Lower Bollinger Band | 0.52 |
Percent B (%b) | 0.32 |
BandWidth | 36.54 |
MACD Line | 0.00 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0083 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.70 | ||||
Resistance 3 (R3) | 0.71 | 0.67 | 0.69 | ||
Resistance 2 (R2) | 0.67 | 0.65 | 0.67 | 0.68 | |
Resistance 1 (R1) | 0.63 | 0.63 | 0.62 | 0.63 | 0.67 |
Pivot Point | 0.60 | 0.60 | 0.59 | 0.60 | 0.60 |
Support 1 (S1) | 0.56 | 0.57 | 0.54 | 0.56 | 0.52 |
Support 2 (S2) | 0.53 | 0.56 | 0.53 | 0.51 | |
Support 3 (S3) | 0.49 | 0.53 | 0.50 | ||
Support 4 (S4) | 0.49 |